{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:29:34Z","timestamp":1795094974438,"version":"4.10.2"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neuropharm.2026.111042","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:50:30Z","timestamp":1779897030000},"page":"111042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Targeting the microbiome-NLRP3-ferroptosis axis in multiple sclerosis: Neuropharmacological implications for microglial dysfunction and demyelination"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3025-2343","authenticated-orcid":false,"given":"Mohamed N.","family":"Fawzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111042_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111333","article-title":"Role of liver X receptor in multiple sclerosis: a long furtive life behind a barrier","volume":"224","author":"Abulaban","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111042_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/NRR.NRR-D-24-01115","article-title":"P2X7 receptors and multiple sclerosis: a potential biomarker and therapeutic target?","volume":"21","author":"Agliardi","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib3","article-title":"Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial","volume":"8","author":"Al","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.neuropharm.2026.111042_bib4","article-title":"The dual role of the COX-2\/PGE2 axis in multiple sclerosis: from pathogenesis to pharmacological inhibition","author":"Al-Dhahi","year":"2025","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib5","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000212332","article-title":"The impact of gut microbiota modulation on disease progression and symptom management in multiple sclerosis (P12-1.004)","volume":"104","author":"Anani","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2026.111042_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46047-6","article-title":"The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial","volume":"13","author":"Asghari","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111042_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/db06-0267","article-title":"Rosiglitazone inhibits Acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator\u2013activated Receptor-\u03b3\u2013Independent mechanism in human arterial smooth muscle cells and macrophages","volume":"56","author":"Askari","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2026.111042_bib8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/bbb\/zbaf071","article-title":"Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial","volume":"89","author":"Baba","year":"2025","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3945\/an.116.014191","article-title":"Influence of diet in multiple sclerosis: a systematic review","volume":"8","author":"Bagur","year":"2017","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111042_bib10","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.3390\/ijms22168370","article-title":"Reviewing the significance of blood\u2013brain barrier disruption in multiple sclerosis pathology and treatment","volume":"22","author":"Balasa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib11","article-title":"The penetration of therapeutics across the blood-brain barrier: classic case studies and clinical implications","volume":"5","author":"Banks","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib13","first-page":"481","article-title":"What's new and what's next in fecal microbiota transplantation?","volume":"19","author":"Baydoun","year":"2025","journal-title":"Biologics"},{"key":"10.1016\/j.neuropharm.2026.111042_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28839-3","article-title":"Dietary non-fermentable fiber prevents autoimmune neurological disease by changing gut metabolic and immune status","volume":"8","author":"Berer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111042_bib15","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115415","article-title":"Nanobodies dismantle post\u2010pyroptotic ASC specks and counteract inflammation","volume":"14","author":"Bertheloot","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1943289","article-title":"Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review","volume":"13","author":"Blais","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.neuropharm.2026.111042_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s12276-026-01647-w","article-title":"Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro models","volume":"58","author":"Blenkle","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01741","article-title":"Intestinal dysbiosis and tryptophan metabolism in autoimmunity","volume":"11","author":"Brown","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib20","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/cells12141872","article-title":"The gut\u2013brain axis as a therapeutic target in multiple sclerosis","volume":"12","author":"Buga","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111042_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib22","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1038\/s41598-022-27086-x","article-title":"Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids","volume":"13","author":"Caetano-Silva","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111042_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/NRR.NRR-D-24-00917","article-title":"NLRP3 inflammasome and gut microbiota\u2013brain axis: a new perspective on white matter injury after intracerebral hemorrhage","volume":"21","author":"Cai","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-025-03454-y","article-title":"Elucidating the specific mechanisms of the gut-brain axis: the short-chain fatty acids-microglia pathway","volume":"22","author":"Cao","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111042_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41420-025-02654-y","article-title":"Redox mechanism of glycerophospholipids and relevant targeted therapy in ferroptosis","volume":"11","author":"Chang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.neuropharm.2026.111042_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","article-title":"Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"6","author":"Chen","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.neuropharm.2026.111042_bib28","article-title":"Inhibition of Acyl-CoA synthetase long-chain family member 4 facilitates neurological recovery after stroke by regulation ferroptosis","volume":"15","author":"Chen","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006347","article-title":"Trimethylamine\u2010N\u2010oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3\u2010SOD2\u2010mtROS signaling pathway","volume":"6","author":"Chen","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.neuropharm.2026.111042_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","article-title":"The interaction between ferroptosis and inflammatory signaling pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib31","article-title":"Interactions between the gut microbiome and ferroptosis in degenerative diseases: novel mechanisms and potential therapeutic strategies","author":"Chen","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neuropharm.2026.111042_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5005136","article-title":"Ferroptosis mediated by lipid reactive oxygen species: a possible causal link of neuroinflammation to neurological disorders","volume":"2021","author":"Cheng","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2026.111042_bib33","doi-asserted-by":"crossref","first-page":"36792","DOI":"10.1039\/D1RA06277H","article-title":"Development of novel, biocompatible, polyester amines for microglia-targeting gene delivery","volume":"11","author":"Choi","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.neuropharm.2026.111042_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8168717","article-title":"Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives","author":"Chu","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1586\/eci.10.66","article-title":"Canakinumab: a human anti-IL-1\u03b2 monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes","volume":"6","author":"Church","year":"2010","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.894298","article-title":"Focus on the role of the NLRP3 inflammasome in multiple sclerosis: pathogenesis, diagnosis, and therapeutics","volume":"15","author":"Cui","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6986175","article-title":"Exploring new inflammatory biomarkers and pathways during LPS-Induced M1 polarization","author":"Cunha","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105344","article-title":"A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis","volume":"81","author":"Dahal","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111042_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178662","article-title":"Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors","volume":"14","author":"Dai","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-023-00343-3","article-title":"Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis","volume":"12","author":"de Dios","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.111042_bib42","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/1873-3468.14894","article-title":"The role of ferroptosis as a regulator of oxidative stress in the pathogenesis of ischemic stroke","volume":"598","author":"Delgado\u2010Mart\u00edn","year":"2024","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2026.111042_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0341867","article-title":"A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability","volume":"21","author":"Deng","year":"2026","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111042_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41419-021-03428-x","article-title":"DAMPs released by pyroptotic cells as major contributors and therapeutic targets for CAR-T-related toxicities","volume":"12","author":"Deng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbadis.2015.10.010","article-title":"Molecular alterations of the blood\u2013brain barrier under inflammatory conditions: the role of endothelial to mesenchymal transition","volume":"1862","author":"Derada Troletti","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/mabs.2.1.10328","article-title":"Canakinumab","volume":"2","author":"Dhimolea","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.neuropharm.2026.111042_bib47","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med. J. (Engl)."},{"key":"10.1016\/j.neuropharm.2026.111042_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109711","article-title":"Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: targeting NLRP3 inflammasome\/TXNIP pathway and autophagy modulation","author":"El-Sayed","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00978","article-title":"Single-arm, non-randomized, time series, single-subject study of fecal microbiota transplantation in multiple sclerosis","volume":"11","author":"Engen","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.111042_bib52","article-title":"Microglial NLRP3 inflammasome's role in multiple sclerosis pathology. CNS neurosci","volume":"30","author":"Fan","year":"2024","journal-title":"Ther"},{"key":"10.1016\/j.neuropharm.2026.111042_bib54","article-title":"Mitigating seizure-induced cognitive deficits in mice induced with pentylenetetrazol by roflumilast through targeting the NLRP3 inflammasome\/BDNF\/SIRT3 pathway and regulating ferroptosis","volume":"366\u2013367","author":"Fawzy","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2026.110704","article-title":"Immune dysregulation in fibromyalgia: targeting the NLRP3 inflammasome-ferroptosis axis as a novel therapeutic strategy for chronic pain","author":"Fawzy","year":"2026","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-026-02490-4","article-title":"Targeting the gut-brain-ferroptosis axis: molecular mechanisms and therapeutic potential in alzheimer's disease and epilepsy","author":"Fawzy","year":"2026","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6973175","article-title":"High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS\/TXNIP pathway in mesangial cells","volume":"2016","author":"Feng","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70440","article-title":"ALOX15\u2010Mediated neuron ferroptosis was involved in diabetic peripheral neuropathic pain","volume":"31","author":"Feng","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.111042_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0322127","article-title":"IL-18 production is required for the generation of a Th1 response during experimental chromoblastomycosis","volume":"20","author":"Ferreira","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111042_bib59","author":"Fetsko"},{"key":"10.1016\/j.neuropharm.2026.111042_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70250","article-title":"From molecular docking to rat models: butyrate from a high\u2010fiber diet inhibits HDAC1and NLRP3Inflammasome to alleviate oxidative stress and inflammation after spinal cord injury","volume":"169","author":"Ganggang","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib61","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","article-title":"Neurodegeneration and demyelination in multiple sclerosis","volume":"112","author":"Garton","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111042_bib62","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.2147\/JIR.S399480","article-title":"TMAO promotes NLRP3 inflammasome activation of microglia aggravating neurological injury in ischemic stroke through FTO\/IGF2BP2","volume":"16","author":"Ge","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib63","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal barrier dysfunction, LPS translocation, and disease development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.neuropharm.2026.111042_bib64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-018-1282-6","article-title":"Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia\/reperfusion injury","volume":"15","author":"Gong","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111042_bib66","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2174\/011570159X352356241126044933","article-title":"The dual role of microglia in multiple sclerosis and its implications for diagnostics and repair","volume":"23","author":"Goulart","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00374","article-title":"Microglia in multiple sclerosis: friend or foe?","volume":"11","author":"Guerrero","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1290234","article-title":"Mechanistic elucidation of ferroptosis and ferritinophagy: implications for advancing our understanding of arthritis","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib68","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1021\/acs.jmedchem.9b00212","article-title":"Novel 15-Lipoxygenase-1 inhibitor protects macrophages from lipopolysaccharide-induced cytotoxicity","volume":"62","author":"Guo","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib71","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.4103\/1673-5374.390964","article-title":"Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression","volume":"19","author":"Han","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib72","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib73","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1007\/s12035-022-02998-x","article-title":"Glibenclamide directly prevents neuroinflammation by targeting SUR1-TRPM4-Mediated NLRP3 inflammasome activation in microglia","volume":"59","author":"He","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib74","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202600272R","article-title":"ALOX15\u2010Derived oxylipins attenuate macrophage inflammatory signaling via a G\u03b1q\u2013PLC\u2013PKC pathway","volume":"40","author":"Hilman","year":"2026","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.111042_bib75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/19490976.2017.1290756","article-title":"Dietary fiber and prebiotics and the gastrointestinal microbiota","volume":"8","author":"Holscher","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.neuropharm.2026.111042_bib76","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/2211-5463.12923","article-title":"Susceptibility to erastin\u2010induced ferroptosis decreases during maturation in a human oligodendrocyte cell line","volume":"10","author":"Hoshino","year":"2020","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.neuropharm.2026.111042_bib78","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s12035-023-03618-y","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 alleviates neurological impairment in the brain of EAE mice","volume":"61","author":"Hou","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib77","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41419-020-2565-2","article-title":"Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype","volume":"11","author":"Hou","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202413197","article-title":"Advances in fecal microbiota transplantation for gut dysbiosis\u2010related diseases","volume":"12","author":"Hou","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib80","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jnc.14604","article-title":"Reduced expression of the ferroptosis inhibitor glutathione peroxidase\u20104 in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"148","author":"Hu","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.705786","article-title":"Progress in understanding ferroptosis and its targeting for therapeutic benefits in traumatic brain and spinal cord injuries","volume":"9","author":"Hu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1593963","article-title":"Ferroptosis in central nervous system injuries: molecular mechanisms, diagnostic approaches, and therapeutic strategies","volume":"19","author":"Huang","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib82","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1191\/1352458504ms1071oa","article-title":"Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis","volume":"10","author":"Huang","year":"2004","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.neuropharm.2026.111042_bib83","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome\u2010driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib85","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/jnc.15519","article-title":"Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease","volume":"159","author":"Jakaria","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4595","article-title":"Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis","volume":"7","author":"Jensen","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.111042_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002714","article-title":"Probiotic Bifidobacterium breve induces IL-10-Producing Tr1 cells in the Colon","volume":"8","author":"Jeon","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neuropharm.2026.111042_bib88","article-title":"Ferroptosis: a new pathway in the interaction between gut microbiota and multiple sclerosis","volume":"30","author":"Jian","year":"2025","journal-title":"Front. Biosci.-Landm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib89","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1594419","article-title":"ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis","volume":"16","author":"Jiang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib91","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-022-04966-8","article-title":"Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis","volume":"13","author":"Jin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib92","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic\/adrenic phosphatidylethanolamines navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1439176","article-title":"Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review","volume":"15","author":"Karimi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib94","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-5728(02)00018-8","article-title":"IL-18 is linked to raised IFN-\u03b3 in multiple sclerosis and is induced by activated CD4+ T cells via CD40\u2013CD40 ligand interactions","volume":"125","author":"Karni","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib95","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/diseases13100345","article-title":"Application and challenges of using probiotic lactobacillus and bifidobacterium to enhance overall health and manage diseases","volume":"13","author":"Kaur","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.neuropharm.2026.111042_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ensci.2016.06.003","article-title":"Antiepileptic drugs in development pipeline: a recent update","volume":"4","author":"Kaur","year":"2016","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.neuropharm.2026.111042_bib97","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10571-024-01496-z","article-title":"Gut\u2013brain axis and neuroinflammation: the role of gut permeability and the kynurenine pathway in neurological disorders","volume":"44","author":"Kearns","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib98","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib99","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10787-017-0401-9","article-title":"Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain","volume":"26","author":"Khan","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111042_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2023.10.008","article-title":"Roles of diet-associated gut microbial metabolites on brain health: cell-to-cell interactions between gut bacteria and the central nervous system","volume":"15","author":"Kim","year":"2024","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111042_bib101","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","article-title":"An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib102","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1038\/s41467-024-46829-0","article-title":"Trimethylamine N-oxide impairs \u03b2-cell function and glucose tolerance","volume":"15","author":"Kong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111042_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1380476","article-title":"The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity","volume":"15","author":"Kopczy\u0144ska","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib104","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2147\/IJN.S106625","article-title":"Lipid nanoparticles for targeted siRNA delivery \u2013 going from bench to bedside","volume":"11","author":"Kotelianski","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuropharm.2026.111042_bib105","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.3390\/ijms24087247","article-title":"Dietary polyphenols, microbiome, and multiple sclerosis: from molecular anti-inflammatory and neuroprotective mechanisms to clinical evidence","volume":"24","author":"La Rosa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib106","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/microorganisms11122840","article-title":"The potential role of fecal microbiota transplant in the reversal or stabilization of multiple sclerosis symptoms: a literature review on efficacy and safety","volume":"11","author":"Laeeq","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.neuropharm.2026.111042_bib107","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.expneurol.2013.10.002","article-title":"Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice","volume":"250","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib108","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1294317","article-title":"Ferroptosis: an important player in the inflammatory response in diabetic nephropathy","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib110","article-title":"The role of ferroptosis in central nervous system damage diseases","volume":"12","author":"Li","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.neuropharm.2026.111042_bib111","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2402547","article-title":"Prebiotic inulin controls Th17 cells mediated central nervous system autoimmunity through modulating the gut microbiota and short chain fatty acids","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.neuropharm.2026.111042_bib112","article-title":"N6-methyladenosine modification regulates cell death in cognitive impairment","author":"Li","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib113","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00702-025-02912-4","article-title":"Ferroptosis: a new target for depression prevention and treatment","volume":"132","author":"Liang","year":"2025","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib114","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/ph15111440","article-title":"Identification of novel arachidonic acid 15-Lipoxygenase inhibitors based on the Bayesian classifier model and computer-aided high-throughput virtual screening","volume":"15","author":"Liao","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2026.111042_bib115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","article-title":"Microglial ferroptotic stress causes non-cell autonomous neuronal death","volume":"19","author":"Liddell","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.111042_bib116","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.1700263","article-title":"New insights into the role of IL-1\u03b2 in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"198","author":"Lin","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib117","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jim.2014.05.018","article-title":"Applying caspase-1 inhibitors for inflammasome assays in human whole blood","volume":"411","author":"Lipinska","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.neuropharm.2026.111042_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113942","article-title":"Microglial HO-1 aggravates neuronal ferroptosis via regulating iron metabolism and inflammation in the early stage after intracerebral hemorrhage","volume":"147","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib118","doi-asserted-by":"crossref","DOI":"10.1177\/17590914221133236","article-title":"New target for prevention and treatment of neuroinflammation: microglia iron accumulation and ferroptosis","volume":"14","author":"Liu","year":"2022","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neuropharm.2026.111042_bib119","article-title":"Regulation of short-chain fatty acids in the immune system","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib122","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1038\/s41401-025-01560-4","article-title":"The role of microglia in neurodegenerative diseases: from the perspective of ferroptosis","volume":"46","author":"Liu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.111042_bib121","article-title":"The crosstalk between probiotics and T cell immunity","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.298","article-title":"Iron homeostasis imbalance and ferroptosis in brain diseases","volume":"4","author":"Long","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.neuropharm.2026.111042_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102152","article-title":"Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis","volume":"42","author":"Lopalco","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111042_bib125","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.3390\/nu16223887","article-title":"Propionic acid impact on multiple sclerosis: evidence and challenges","volume":"16","author":"Lorefice","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2026.111042_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.161251","article-title":"Microglial membrane-coated nanoparticles for ACSL4-siRNA delivery in Parkinson's disease","volume":"509","author":"Lu","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.neuropharm.2026.111042_bib127","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10753-025-02355-9","article-title":"Autophagy-NLRP3 inflammasome crosstalk in microglia: a therapeutic target for multiple sclerosis","volume":"49","author":"Lu","year":"2026","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2026.111042_bib128","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2147\/NDT.S140634","article-title":"The role of microglia in multiple sclerosis","volume":"13","author":"Luo","year":"2017","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2026.111042_bib129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41423-022-00883-0","article-title":"Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis","volume":"19","author":"Luoqian","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-022-01090-z","article-title":"ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.111042_bib131","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201348R","article-title":"Possible role of the NLRP3 inflammasome and the gut\u2013brain axis in multiple sclerosis\u2010related depression","volume":"37","author":"Maciak","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.111042_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.619257","article-title":"IL-1 inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives","volume":"11","author":"Malcova","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib133","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200100","article-title":"Increased NLRP3 inflammasome activation and pyroptosis in patients with multiple sclerosis with fingolimod treatment failure","volume":"10","author":"Malhotra","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117932","article-title":"Research progress on ferroptosis in cerebral hemorrhage","volume":"185","author":"Mao","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111042_bib135","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfae069.1089","article-title":"Ferroptotic proteins ACSL4 and ALOX15 as therapeutic targets in AKI","volume":"39","author":"Mauvec\u00edn","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.neuropharm.2026.111042_bib136","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202500518","article-title":"LIBX\u2010A401: a novel selective inhibitor of acyl\u2010CoA synthetase long chain family member 4 (ACSL4) and its binding mode","volume":"64","author":"Mazhari Dorooee","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuropharm.2026.111042_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis","volume":"5","author":"McFarland","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib138","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2026.111042_bib139","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00702-017-1732-9","article-title":"The IL-1\u03b2 phenomena in neuroinflammatory diseases","volume":"125","author":"Mendiola","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.644319","article-title":"Delivery platforms for CRISPR\/Cas9 genome editing of glial cells in the central nervous system","volume":"3","author":"Meneghini","year":"2021","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.neuropharm.2026.111042_bib141","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1039\/D5FO00425J","article-title":"Alliin from garlic as a neuroprotective agent attenuates ferroptosis in vitro and in vivo via inhibiting ALOX15","volume":"16","author":"Meng","year":"2025","journal-title":"Food Funct."},{"key":"10.1016\/j.neuropharm.2026.111042_bib142","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","article-title":"The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer's disease","volume":"68","author":"Milner","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-27300-w","article-title":"Live probiotic bacteria administered in a pathomimetic leaky gut chip ameliorate impaired epithelial barrier and mucosal inflammation","volume":"12","author":"Min","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111042_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14724","article-title":"Effect of probiotics supplementation on disease progression, depression, general health, and anthropometric measurements in relapsing\u2010remitting multiple sclerosis patients: a systematic review and meta\u2010analysis of clinical trials","volume":"75","author":"Mirashrafi","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2026.111042_bib145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s43856-024-00565-0","article-title":"Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis","volume":"4","author":"Mirza","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115861","article-title":"Interleukin-1\u03b2 converting enzyme (ICE): a comprehensive review on discovery and development of caspase-1 inhibitors","volume":"261","author":"Modi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.960761","article-title":"Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis","volume":"13","author":"Moles","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib148","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/nu18030372","article-title":"Prebiotics and gut health: mechanisms, clinical evidence, and future directions","volume":"18","author":"Monteiro","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2026.111042_bib149","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1080\/1028415X.2022.2128010","article-title":"Effects of anti-inflammatory-antioxidant-rich diet and co-supplemented synbiotics intervention in patients with progressive forms of multiple sclerosis: a single-center, single-blind randomized clinical trial","volume":"26","author":"Moravejolahkami","year":"2023","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in neuroinflammation and neurodegeneration: from understanding to therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib151","first-page":"435","article-title":"Microbiota-driven mechanisms in multiple sclerosis: pathogenesis, therapeutic strategies, and biomarker potential","volume":"14","author":"Nemati","year":"2025","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.neuropharm.2026.111042_bib152","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awn109","article-title":"Debris clearance by microglia: an essential link between degeneration and regeneration","volume":"132","author":"Neumann","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2026.111042_bib153","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11306-011-0306-3","article-title":"Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis","volume":"8","author":"Noga","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.neuropharm.2026.111042_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbc.2025.100061","article-title":"Oxidized phospholipids in ferroptosis, immunity and inflammation","volume":"14","author":"O'Donnell","year":"2025","journal-title":"Redox Biochem. Chem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib154","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70154","article-title":"Exploring the role of microglial cells in the gut\u2013brain axis communication: a systematic review","volume":"169","author":"Ortiz\u2010Samur","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib155","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nn.3161","article-title":"Immune surveillance in the central nervous system","volume":"15","author":"Ousman","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib157","article-title":"Short chain fatty acids (SCFAs)-Mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib158","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s12276-021-00703-x","article-title":"Regulation of common neurological disorders by gut microbial metabolites","volume":"53","author":"Park","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib159","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3390\/ijms20122876","article-title":"Phytochemicals as novel therapeutic strategies for NLRP3 inflammasome-related neurological, metabolic, and inflammatory diseases","volume":"20","author":"Pellegrini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib160","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111042_bib161","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/jnc.15831","article-title":"Ferroptosis and central nervous system demyelinating diseases","volume":"165","author":"Qin","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib162","article-title":"Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Rahimlou","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib163","series-title":"Discovery of ML351, a Potent and Selective Inhibitor of Human 15-Lipoxygenase-1","author":"Rai","year":"2010"},{"key":"10.1016\/j.neuropharm.2026.111042_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111042_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24152-2","article-title":"Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve","volume":"12","author":"Rayatpour","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111042_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1652796","article-title":"The link between gut microbiota and multiple sclerosis from the perspective of barrier function","volume":"16","author":"Ren","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib168","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-024-03042-6","article-title":"Differential contribution of THIK-1 K+ channels and P2X7 receptors to ATP-mediated neuroinflammation by human microglia","volume":"21","author":"Rifat","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111042_bib169","doi-asserted-by":"crossref","first-page":"19946","DOI":"10.18632\/oncotarget.4650","article-title":"CX3CR1 in multiple sclerosis","volume":"6","author":"Rivest","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2026.111042_bib170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.111042_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.604179","article-title":"The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology","volume":"11","author":"Rutsch","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib173","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","article-title":"Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration","volume":"26","author":"Ryan","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib172","author":"Ryan"},{"key":"10.1016\/j.neuropharm.2026.111042_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01390","article-title":"Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis","volume":"11","author":"Saresella","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00288","article-title":"NLRP3-Inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury","volume":"3","author":"Savage","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib176","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anaerobe.2018.04.001","article-title":"Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection","volume":"53","author":"Seekatz","year":"2018","journal-title":"Anaerobe"},{"key":"10.1016\/j.neuropharm.2026.111042_bib177","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.47058","article-title":"Unraveling the gut-brain axis in multiple sclerosis: exploring dysbiosis, oxidative stress, and therapeutic insights","author":"Sharifa","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.neuropharm.2026.111042_bib178","article-title":"Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm (Beijing)."},{"key":"10.1016\/j.neuropharm.2026.111042_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1753617","article-title":"The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease","volume":"17","author":"Shi","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167737","article-title":"Microglial pyroptosis drives neuropathic pain and targeting NLRP3 alleviates pain and neuroinflammation","volume":"1871","author":"Shin","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib181","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.2147\/JIR.S461795","article-title":"Microglia in ischemic stroke: pathogenesis insights and therapeutic challenges","volume":"17","author":"Shui","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib183","doi-asserted-by":"crossref","DOI":"10.36922\/GPD025180034","article-title":"NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome at the crossroads of dysbiosis and disease: a target for microbiome-modulated inflammation","author":"Singh","year":"2026","journal-title":"Gene & Prot. Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib182","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plipres.2018.11.001","article-title":"Emerging role of 12\/15-Lipoxygenase (ALOX15) in human pathologies","volume":"73","author":"Singh","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib184","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use","volume":"27","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111042_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1149618","article-title":"Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration","volume":"14","author":"Solanki","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib186","series-title":"Clinical Aspects of Multiple Sclerosis Essentials and Current Updates","first-page":"135","article-title":"Disease-modifying therapies","author":"Sriwastava","year":"2024"},{"key":"10.1016\/j.neuropharm.2026.111042_bib187","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.4049\/jimmunol.175.4.2630","article-title":"IL-Converting Enzyme\/Caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients","volume":"175","author":"Stack","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib188","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111042_bib189","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2018.09.008","article-title":"Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction?","volume":"133","author":"Stoyanovsky","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105762","article-title":"A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: trial feasibility, supplement tolerability and symptom abatement","volume":"89","author":"Straus Farber","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111042_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105920","article-title":"Ferritinophagy promotes microglia ferroptosis to aggravate neuroinflammation induced by cerebral ischemia-reperfusion injury via activation of the cGAS-STING signaling pathway","volume":"183","author":"Sui","year":"2025","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.111042_bib192","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.111042_bib193","first-page":"1","article-title":"Lipid metabolism in microglia: emerging mechanisms and therapeutic opportunities for neurodegenerative diseases","volume":"56","author":"Sun","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib194","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jphs.2017.09.032","article-title":"Glibenclamide inhibits NLRP3 inflammasome-mediated IL-1\u03b2 secretion in human trophoblasts","volume":"135","author":"Tamura","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib197","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib198","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1622544","article-title":"Ferroptosis in neurodegenerative diseases: potential mechanisms of exercise intervention","volume":"13","author":"Tang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib196","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2147\/IDR.S254403","article-title":"The impact of gut microbiota disorders on the blood\u2013brain barrier","volume":"13","author":"Tang","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.neuropharm.2026.111042_bib199","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ana.25244","article-title":"A probiotic modulates the microbiome and immunity in multiple sclerosis","volume":"83","author":"Tankou","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1422249","article-title":"Screening NLRP3 drug candidates in clinical development: lessons from existing and emerging technologies","volume":"15","author":"Tengesdal","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib201","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/medicina58010084","article-title":"Current status and future therapeutic options for fecal microbiota transplantation","volume":"58","author":"Tkach","year":"2022","journal-title":"Medicina (B. Aires)."},{"key":"10.1016\/j.neuropharm.2026.111042_bib202","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676016","article-title":"Review: the nutritional management of multiple sclerosis with propionate","volume":"12","author":"Tobin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105743","article-title":"A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals","volume":"116","author":"Tr\u00e4ger","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuropharm.2026.111042_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/5460302","article-title":"Natural compounds as regulators of NLRP3 inflammasome-mediated IL-1\u03b2Production","volume":"2016","author":"T\u0151zs\u00e9r","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib206","doi-asserted-by":"crossref","DOI":"10.4253\/wjge.v18.i1.113133","article-title":"Science of fecal microbiota transplant: from history to cutting-edge clinical practice","volume":"18","author":"Uppala","year":"2026","journal-title":"World J. Gastrointest. Endosc."},{"key":"10.1016\/j.neuropharm.2026.111042_bib207","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","article-title":"Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression","volume":"30","author":"Van San","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2026.111042_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.723886","article-title":"Gut metabolite Trimethylamine-N-Oxide in atherosclerosis: from mechanism to therapy","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2023.112567","article-title":"Effectiveness of targeting the NLRP3 inflammasome by using natural polyphenols: a systematic review of implications on health effects","volume":"165","author":"Wang","year":"2023","journal-title":"Food Res. Int."},{"key":"10.1016\/j.neuropharm.2026.111042_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107786","article-title":"The regulation of microglia by aging and autophagy in multiple sclerosis","volume":"216","author":"Wang","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102262","article-title":"ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury","volume":"51","author":"Wang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02325","article-title":"The gut-microglia connection: implications for central nervous system diseases","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib213","doi-asserted-by":"crossref","DOI":"10.37349\/emed.2025.1001339","article-title":"TMAO metaorganismal pathway and chronic inflammatory diseases","volume":"6","author":"Wang","year":"2025","journal-title":"Explor. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115962","article-title":"TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury","volume":"170","author":"Wei","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111042_bib215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41423-022-00941-7","article-title":"Ferroptosis drives immune-mediated neurodegeneration in multiple sclerosis","volume":"20","author":"White","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib216","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1570159X20666221003085508","article-title":"Targeting gut dysbiosis and microbiome metabolites for the development of therapeutic modalities for neurological disorders","volume":"22","author":"Wiefels","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.922331","article-title":"Microglia pyroptosis: a candidate target for neurological diseases treatment","volume":"16","author":"Wu","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116261","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus","volume":"172","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111042_bib218","article-title":"Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib220","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.86","article-title":"Inhibition of 12\/15-lipoxygenase by baicalein induces microglia PPAR\u03b2\/\u03b4: a potential therapeutic role for CNS autoimmune disease","volume":"4","author":"Xu","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib222","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib221","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/antiox13040395","article-title":"The interplay between ferroptosis and neuroinflammation in central neurological disorders","volume":"13","author":"Xu","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2026.111042_bib223","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1038\/s41598-017-08055-1","article-title":"Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses","volume":"7","author":"Yamanashi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111042_bib224","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.111042_bib226","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.csbj.2023.03.017","article-title":"Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis","volume":"21","author":"Yang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.neuropharm.2026.111042_bib225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib227","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.111042_bib228","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2026.111042_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319755","article-title":"The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: a worldwide systematic review and meta-analysis","volume":"20","author":"Zangeneh","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111042_bib230","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41419-024-06807-2","article-title":"Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111042_bib237","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.7150\/ijbs.98592","article-title":"Exosomal miR-375-3p mediated lipid metabolism, ferritinophagy and CoQ-dependent pathway contributes to the ferroptosis of keratinocyte in SJS\/TEN","volume":"21","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib232","article-title":"The gut microbiome: linking dietary fiber to inflammatory diseases","volume":"14","author":"Zhang","year":"2022","journal-title":"Med. Microecol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib231","first-page":"1","article-title":"A protective role of glibenclamide in inflammation-associated injury","volume":"2017","author":"Zhang","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2026.111042_bib235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13578-024-01256-y","article-title":"Role of NLRP3 inflammasome in central nervous system diseases","volume":"14","author":"Zhang","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.neuropharm.2026.111042_bib236","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4103\/1673-5374.387974","article-title":"Gut flora in multiple sclerosis: implications for pathogenesis and treatment","volume":"19","author":"Zhang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib238","article-title":"The role of NLRP3 inflammasome in multiple sclerosis: pathogenesis and pharmacological application","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib234","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/ijmm.2023.5238","article-title":"Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases","volume":"51","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib233","article-title":"Microglia in the context of multiple sclerosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib241","doi-asserted-by":"crossref","DOI":"10.1002\/cns.70850","article-title":"Targeting ferroptosis pathways for synaptic protection in sevoflurane\u2010induced cognitive impairment: a nanomedicine approach","volume":"32","author":"Zhao","year":"2026","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.111042_bib239","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1023896","article-title":"Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates","volume":"9","author":"Zhao","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.neuropharm.2026.111042_bib240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-024-02217-2","article-title":"Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance","volume":"24","author":"Zhao","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neuropharm.2026.111042_bib242","doi-asserted-by":"crossref","DOI":"10.34133\/research.0135","article-title":"Unresolved excess accumulation of myelin-derived cholesterol contributes to scar formation after spinal cord injury","volume":"6","author":"Zheng","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.neuropharm.2026.111042_bib243","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib244","article-title":"Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JIR.S564892","article-title":"A single-cell transcriptomic atlas elucidates a microglial gene signature linking ferroptosis to mitochondrial dysfunction in epilepsy","volume":"19","author":"Zhong","year":"2026","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2026.111042_bib246","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbi.2023.02.012","article-title":"ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression","volume":"109","author":"Zhou","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111042_bib247","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s11010-024-05150-6","article-title":"The role of ACSL4 in stroke: mechanisms and potential therapeutic target","volume":"480","author":"Zhuo","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111042_bib248","doi-asserted-by":"crossref","first-page":"9951","DOI":"10.1038\/s41467-025-64906-w","article-title":"Age-impaired remyelination is associated with dysregulated microglial transitions","volume":"16","author":"Zia","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111042_bib250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood\u2013brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.111042_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104934","article-title":"Iron in multiple sclerosis \u2013 neuropathology, immunology, and real-world considerations","volume":"78","author":"Zierfuss","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111042_bib251","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/cells13060497","article-title":"Gut\u2013brain interactions and their impact on astrocytes in the context of multiple sclerosis and beyond","volume":"13","author":"Zi\u00dfler","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111042_bib252","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.7150\/ijbs.70644","article-title":"Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43\/NLRP3 signaling","volume":"18","author":"Zuo","year":"2022","journal-title":"Int. J. Biol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:41:13Z","timestamp":1780548073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":251,"alternative-id":["S0028390826002157"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111042","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the microbiome-NLRP3-ferroptosis axis in multiple sclerosis: Neuropharmacological implications for microglial dysfunction and demyelination","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111042"}}